ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997

Agreement Nears On New Guidelines For Center Grants

November 14, 1980

Diet & Nutrition Wins Ok To Use Program Grants

February 20, 1976

Funding Opportunities

September 27, 2002

NCI-Approved Clinical Trials

October 27, 2006

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003